Newsflash December 2013: Cytotoxicity testing performed on…

“Such results demonstrate the efficiency of MPXX™ treatment and are clearly establishing, for the first time, that it is possible to produce gloves virtually free of chemical residues and hence fight the ever growing irritant contact dermatitis caused by gloves”, states Michiel Paping CEO of Budev BV.

When the innovative testing technology from BMK helps proving the efficiency of the innovative glove batch washing technology MPXX™ from Budev.